PRME
NASDAQ · Biotechnology
Prime Medicine Inc
$4.72
-0.52 (-9.92%)
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Price Target
Analyst Price Target
+815.0% upside
Low Target
$33.60
Average Target
$43.19
High Target
$71.66
Current Price
$4.72
Current
$4.72
$4.72
Target
$43.19
$43.19
$33.60
$43.19 avg
$71.66
Scenario Analysis
Bear Case
$33.60
611.9%
Low target
Base Case
$43.19
+815.0%
Avg target
Bull Case
$71.66
+1,418.2%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$5.91
-20.1% from high
52-Week Low
$2.67
+76.8% from low
Target vs 52W High
$43.19
+630.8% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |